Super Lawyers
AVVO
Million Dollar Advocates Forum
Martindale-Hubbell
BBB Accredited Business

Nokia Public records indicate that a class action lawsuit has been filed on behalf of investors in Nokia (NYSE:NOK) in connection to alleged securities law violations by NOK. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in Nokia between October 25, 2018 and March 21, 2019.

The class action complaint specifically alleges that during the period in question, NOK provided false and/or misleading material information and/or failed to disclose adverse material information to the public, namely: that the company Alcatel-Lucent, which Nokia previously acquired, did not have adequate internal controls and some of its business practices were materially noncompliant; that Nokia had not performed sufficient due diligence of Alcatel before it acquired the company; that prior to its acquisition of Alcatel, Nokia had inadequate internal controls governing the integration of Alcatel; that consequently the company faced a risk of civil and criminal scrutiny and action; and that consequently the company’s statements to the public during the relevant period were false and misleading. When the company disclosed in an SEC filing on March 21, 2019, that it had recently been “made aware of certain practices relating to compliance issues” in connection with Alcatel, and informed investors that it had launched “an internal investigation and voluntarily reported the matter to the relevant regulatory authorities,” the price of the company’s ADRs declined about 6%, falling $0.38/share to a close of $5.88/share on the following day. The complaint alleges that when true facts emerged, investors suffered losses.

According to the company’s website, Nokia is a “multinational communications and information technology company” involved in the development and sale of network equipment, services, and licensing, which it sells across the globe. The company’s customers “include service providers whose combined networks support 6.1 billion subscriptions,” public and private companies, and consumers. Its portfolio of products includes 5G technology, mobile transport solutions, business support systems, networks, cloud technology, data center infrastructure, analytics, operations support systems, optical networks, and radio access networks. The company trades on the New York Stock Exchange under the symbol NOK.

Apyx MedicalPublic records indicate that a class action lawsuit has been filed on behalf of investors in Apyx Medical (NASDAQ:APYX) in connection to alleged securities law violations by APYX. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in Apyx Medical. between August 1, 2018 and April 1, 2019.

The class action complaint specifically alleges that during the period in question, APYX provided false and/or misleading material information and/or failed to disclose adverse material information to the public, namely: that the company’s J-Plasma clinical study had not reached its primary efficacy endpoint; that the study, whose subject involved the use in dermal resurfacing of a product for soft tissue cutting, coagulation, and ablation of soft tissue, failed to support the company’s regulatory clearance application; that the company’s application to use the J-Plasma product for dermal resurfacing had poor prospects of receiving clearance from regulators; and that consequently the company’s positive statements to the public during the relevant period were materially false and/or misleading. When an analysis published on February 21, 2019 alleged that the company’s J-Plasma study might have fallen short of endpoints, APYX declined in value by almost 25%, falling $2.10/share to a close of $6.40 on that date. When the company announced on April 1, 2019 that it had withdrawn its FDA application for the product, in response to FDA concerns about the device’s clinical performance, the company also disclosed that the study had not met its primary endpoint. Following this disclosure, APYX declined in value by more than 35%, falling $2.49/share to a close of $4.46/share on April 2, 2019. The complaint alleges that when true facts emerged, investors suffered losses.

According to the company’s website, Apyx Medical is a medical technology company “solely focused on bringing transformative solutions to the physicians and patients it serves.” Its products include Renuvon, a helium plasma technology sold in the cosmetic surgery market, and the J-Plasma system, which its description says “allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma.” The company trades on the Nasdaq exchange under the symbol APYX.

Fusion ConnectPublic records indicate that a class action lawsuit has been filed on behalf of investors in Fusion Connect (OTC:FSNN) in connection to alleged securities law violations by FSNN. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in Fusion Connect between August 14, 2018, and April 2, 2019.

The class action complaint specifically alleges that during the period in question, FSNN provided false and/or misleading material information and/or failed to disclose adverse material information to the public, namely: that imprecision in the process by which certain of its subsidiaries made capitalizations of costs resulted in overstatements in its earnings for the quarters ending June 30, 2018, and September 30, 2018; and that consequently the company’s statements to the public during the relevant period were false and misleading. Specifically, the complaint alleges that the company’s Birch Holdings subsidiaries used an imprecise capitalization process in connection with its customer on-boarding procedures that led to overstatements of earnings or net loss between $1.7 million and $2.3 million in the quarter ending on June 30; and between $3.4 million and $4.1 million in the quarter ending on September 30. The complaint alleges that when true facts emerged, investors suffered losses.

According to the company’s website, Fusion Connect is a technology company that provides “integrated cloud solutions” for enterprise customers of all sizes. It describes its “advanced, proprietary service platform” as enabling “leading edge” cloud solutions, such as voice and communications, connectivity, storage, and computing. In June 2019 the company announced that it had entered into a Restructuring Support Agreement with “lenders holding more than 66.67% of the aggregate outstanding principal amount of its first lien loans.” Its Chairman and CEO said in a statement, “”We are grateful for the continued financial support of our lenders and the continued support, loyalty and trust of our stakeholders, and we are confident that we will emerge stronger than ever.” The company is headquartered in New York, New York and trades over-the-counter under the symbol FSNN.

Taronis TechnologiesPublicly available records indicate that a class action lawsuit has been filed on behalf of investors in Taronis Technologies (NASDAQ:TRNX) in connection to alleged violations of securities laws by TRNX. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in Taronis Technologies between January 28, 2019 and February 12, 2019.

The class action complaint specifically alleges that during the period in question, TRNX provided false and/or misleading material information and/or failed to disclose adverse material information to the public, namely: that the company had no contract with San Diego; that the company as well as its managing officers participated in a scheme to defraud other parties; and that consequently the company’s statements to the public during the relevant period were false and misleading. The complaint alleges that when true facts emerged, investors suffered losses.

According to the company’s website, Taronis Technologies is a technology company that “owns a patented plasma arc technology that enable two end use applications for fuel generation and water decontamination.” Its product allows for the conversion of waste streams based on hydrocarbons to be converted into “fossil fuel substitutes.” Taronis Technologies is also involved in the development of market uses for those fossil fuel products, including propane replacements and natural gases. The company’s wholly owned distributors include ESSI, Green Arc Supply, Paris Oxygen, and Trico Welding Supply. The company trades on the Nasdaq exchange under the symbol TRNX.

Debra Bourne Public records published by the Financial Industry Regulatory Authority (FINRA) and accessed on April 16, 2019 indicate that New Jersey-based First Standard Financial Company broker Debra Bourne has received resolved or pending customer disputes. Fitapelli Kurta is interested in hearing from investors who have complaints regarding Ms. Bourne (CRD# 1352344).

Debra Bourne has spent 19 years in the securities industry and has been registered with First Standard Financial Company in Red Bank, New Jersey since 2016. Previous registrations include National Securities Corporation in Red Bank, New Jersey (2014-2016); Oppenheimer & Company in Red Bank, New Jersey (2008-2014); Janney Montgomery Scott in Red Bank, New Jersey (2004-2008); Morgan Stanley DW in Purchase, New York (1999-2004); First Union Securities in St. Louis, Missouri (1999-2000); and First Union Capital Markets in Charlotte, North Carolina (1999). She has passed three securities industry examinations: Series 63 (Uniform Securities Agent State Law Examination), which she obtained on October 20, 1999; SIE (Securities Industry Essentials Examination), which she obtained on October 1, 2018; and Series 7 (General Securities Representative Examination), which she obtained on September 21, 1999. She is a registered broker with 24 US states and territories.

According to her BrokerCheck report, she has received one customer complaint and four pending customer complaints.

Thomas MarinoPublicly available records provided by the Financial Industry Regulatory Authority (FINRA) and accessed on May 13, 2019 indicate that Florida-based RM Stark & Company broker Thomas Marino has received resolved or pending customer complaints. Fitapelli Kurta is interested in speaking to investors who have complaints regarding Mr. Marino (CRD# 4438533).

Thomas Marino has spent 17 years in the securities industry and has been registered with RM Stark & Company in Delray Beach, Florida since 2012. Previous registrations include JW Cole Financial in Sarasota, Florida (2009-2012); Newbridge Securities in Boca Raton, Florida (2009); Summit Brokerage Services in West Palm Beach, Florida (2008-2009); Morgan Stanley & Company in Sarasota, Florida (2007-2008); Morgan Stanley DW in Sarasota, Florida (2005-2007); and AG Edwards & Sons in St. Louis, Missouri (2001-2005). He has passed four securities industry examinations: Series 63 (Uniform Securities Agent State Law Examination), which he obtained on December 2, 2001; SIE (Securities Industry Essentials Examination), which he obtained on October 1, 2018; Series 7 (General Securities Representative Examination), which he obtained on October 3, 2001; and Series 9 (General Securities Sales Supervisor – Options Module Examination), which he obtained on December 9, 2005. He is a registered broker with four US states: California, Florida, New Jersey, and New York.

According to his BrokerCheck report, he has received one customer complaint, one pending customer complaint, and one denied customer complaint, and he resigned from a former employer in connection to alleged rule violations.

Craig SherrePublic records published by the Financial Industry Regulatory Authority (FINRA) and accessed on May 13, 2019 indicate that New York-based Janney Montgomery Scott broker/adviser Craig Sherrer has received a pending customer complaint. Fitapelli Kurta is interested in hearing from investors who have complaints regarding Mr. Sherrer (CRD# 5972142).

Craig Sherrer has spent seven years in the securities industry and has been registered with Janney Montgomery Scott in Garden City, New York since April 2018. Previous registrations include Newbridge Securities Corporation in New York, New York (2012-2018) and Investors Capital Corporation in New York, New York (2011-2012). He has passed four securities industry examinations: Series 66 (Uniform Combined State Law Examination), which he obtained on August 9, 2018; Series 63 (Uniform Securities Agent State Law Examination), which he obtained on March 9, 2012; SIE (Securities Industry Essentials Examination), which he obtained on October 1, 2018; and Series 7 (General Securities Representative Examination), which he obtained on November 22, 2011. He is a registered broker and investment adviser with 39 US states and territories.

According to his BrokerCheck report, he has received one pending customer complaint.

John ForresterPublic records provided by the Financial Industry Regulatory Authority (FINRA) and accessed on May 13, 2019 indicate that Florida-based Newbridge Securities Corporation broker John Forrester has received resolved or pending customer complaints. Fitapelli Kurta is interested in speaking to investors who have complaints regarding Mr. Forrester (CRD# 728188).

John Forrester has spent 37 years in the securities industry and has been registered with Newbridge Securities Corporation in Boca Raton, Florida since 2010. Previous registrations include Wasserman & Associates in Myrtle Beach, South Carolina (2000-2010); Thos. K. Wasserman & Associates in Boynton Beach, Florida (1995-1999); Dean Witter Reynolds in Purchase, New York (1991-1995); Prudential Securities in New York, New York (1988-1991); Thomson McKinnon Securities (1984-1988); Richardson Greenshields Securities (1984); Arch W. Roberts & Company (1982-1984); Cralin & Company (1982); Fittin Cunningham & Lauzon (1981-1982); and Herzfeld & Stern (1981). He has passed three securities industry examinations: Series 63 (Uniform Securities Agent State Law Examination), which he obtained on August 13, 1984; SIE (Securities Industry Essentials Examination), which he obtained on October 1, 2018; and Series 7 (General Securities Representative Examination), which he obtained on April 11, 1981. He is a registered broker with 18 US states and territories.

According to his BrokerCheck report, he has received three customer complaints and one pending customer complaint.

Jeb BashawPublic records provided by the Financial Industry Regulatory Authority (FINRA) and accessed on May 13, 2019 indicate that Texas-based International Assets Advisory broker/adviser Jeb Bashaw was recently sanctioned by FINRA in connection to alleged rule violations. Fitapelli Kurta is interested in hearing from investors who have complaints regarding Mr. Bashaw (CRD# 1251491).

Jeb Bashaw has spent 33 years in the securities industry and has been registered with International Assets Advisory in Houston, Texas since 2014. Previous registrations include Wunderlich Securities in Houston, Texas (2014); LPL Financial in Houston, Texas (2001-2014); UBS Painewebber in Weehawken, New Jersey (2000-2001); JC Bradford & Company in New York, New York (1998-2000); SunTrust Equitable Securities in Atlanta, Georgia (1994-1998); Augusta Securities Corporation in Houston, Texas (1991-1994); First America Equities Corporation (1990-1991); Thomas F. White & Company in San Francisco, California (1991); Kidder Peabody & Company (1986-1988); and Merrill Lynch (1984-1986). He has passed seven securities industry examinations: Series 65 (Uniform Investment Adviser Law Examination), which he obtained on May 12, 1997; Series 63 (Uniform Securities Agent State Law Examination), which he obtained on June 26, 1984; SIE (Securities Industry Essentials Examination), which he obtained on October 1, 2018; Series 3 (National Commodity Futures Examination), which he obtained on February 7, 2001; Series 7 (General Securities Representative Examination), which he obtained on June 16, 1984; Series 53 (Municipal Securities Principal Examination), which he obtained on March 13, 2006; and Series 8 (General Securities Sales Supervisor Examination [Options Module & General Module]), which he obtained on May 30, 1997. He is a registered broker and investment adviser with four US states: Georgia, Maryland, Pennsylvania, and Texas.

According to his BrokerCheck report, he has received three customer complaints and one regulatory sanction.

Robert HartPublicly available records published by the Financial Industry Regulatory Authority (FINRA) and accessed on May 13, 2019 indicate that California-based Stifel Nicolaus broker/adviser Robert Hart has received a pending customer complaint. Fitapelli Kurta is interested in speaking to investors who have complaints regarding Mr. Hart (CRD# 2313194).

Robert Hart has spent 26 years in the securities industry and has been registered with Morgan Stanley in Sea Girt, New Jersey since 2017. Previous registrations include Wells Fargo Clearing Services in Spring Lake, New Jersey (2012-2017); RBC Capital Markets in Wall Township, New Jersey (2008-2012); UBS Financial Services in Red Bank, New Jersey (2004-2008); Morgan Stanley DW in Purchase, New York (1994-2004); Equico Securities in New York, New York (1993-1994); and the Equitable Life Assurance Society of the United States in New York, New York (1993-1994). He has passed eight securities industry examinations: Series 65 (Uniform Investment Adviser Law Examination), which he obtained on July 3, 2002; Series 63 (Uniform Securities Agent State Law Examination), which he obtained on February 18, 1993; SIE (Securities Industry Essentials Examination), which he obtained on October 1, 2018; Series 31 (Futures Managed Funds Examination), which he obtained on April 18, 1995; Series 7 (General Securities Representative Examination), which he obtained on October 1, 1994; Series 6 (Investment Company Products/Variable Contracts Representative Examination), which he obtained on January 27, 1993; Series 10 (General Securities Sales Supervisor – General Module Examination), which he obtained on April 17, 2001; and Series 9 (General Securities Sales Supervisor – Options Module Examination), which he obtained on March 2, 2001. He is a registered broker and investment adviser with 22 US states and territories: California, Connecticut, Delaware, Florida, Georgia, Hawaii, Indiana, Louisiana, Maryland, Massachusetts, Montana, Nevada, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina, Vermont, and Virginia.

According to his BrokerCheck report, he has received one pending customer complaint and two denied customer complaints.